APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antidiarrheal Microorganisms

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antidiarrheal Microorganisms Market Outlook and Growth Opportunities 2026

Report ID 173966110427 December 2025205 pages

Choose your research edition.

Industry ResearchAntidiarrheal Microorganisms Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidiarrheal Microorganisms Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Antidiarrheal Microorganisms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidiarrheal Microorganisms Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidiarrheal Microorganisms Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Antidiarrheal Microorganisms market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antidiarrheal Microorganisms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antidiarrheal Microorganisms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antidiarrheal Microorganisms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antidiarrheal Microorganisms market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antidiarrheal Microorganisms market include Zhejiang Jingxin Pharmaceutical Co., Ltd., Shanghai SPH Xinyi Pharmaceutical Co., Ltd., Inner Mongolia Shuangqi Pharmaceutical Co., Ltd., Livzon Pharmaceutical Factory of Livzon Group, Sinovac Biotech Co., Ltd., Jincheng Haisi Pharmaceutical Co., Ltd., Hangzhou Yuanda Biopharmaceutical Co., Ltd., Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. and Beijing Hanmei Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antidiarrheal Microorganisms market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antidiarrheal Microorganisms and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antidiarrheal Microorganisms sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antidiarrheal Microorganisms market size, projected growth trends, production technologies, key applications, and end-use industries.

Antidiarrheal Microorganisms Segment by Company

Zhejiang Jingxin Pharmaceutical Co., Ltd.

Shanghai SPH Xinyi Pharmaceutical Co., Ltd.

Inner Mongolia Shuangqi Pharmaceutical Co., Ltd.

Livzon Pharmaceutical Factory of Livzon Group

Sinovac Biotech Co., Ltd.

Jincheng Haisi Pharmaceutical Co., Ltd.

Hangzhou Yuanda Biopharmaceutical Co., Ltd.

Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd.

Beijing Hanmei Pharmaceutical Co., Ltd.

VWR

Vermicon AG

Tangsonsbio

Pepto Bismol

Goerlich Pharma

Chr. Hansen

Biofermin

Aptalis Pharma SAS

Antidiarrheal Microorganisms Segment by Type

Bifidobacterium Live Bacteria

Bacillus Subtilis Live Bacteria

Bacillus Licheniformis Live Bacteria

Other

Antidiarrheal Microorganisms Segment by Application

Pharmacy

Hospital

Clinic

Other

Antidiarrheal Microorganisms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antidiarrheal Microorganisms status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antidiarrheal Microorganisms market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antidiarrheal Microorganisms significant trends, drivers, influence factors in global and regions.

6. To analyze Antidiarrheal Microorganisms competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiarrheal Microorganisms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidiarrheal Microorganisms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiarrheal Microorganisms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antidiarrheal Microorganisms market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antidiarrheal Microorganisms industry.

Chapter 3: Detailed analysis of Antidiarrheal Microorganisms manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antidiarrheal Microorganisms in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antidiarrheal Microorganisms in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antidiarrheal Microorganisms Industry Trends Table 2. Antidiarrheal Microorganisms Industry Drivers Table 3. Antidiarrheal Microorganisms Industry Opportunities and Challenges Table 4. Antidiarrheal Microorganisms Industry Restraints Table 5. Global Antidiarrheal Microorganisms Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antidiarrheal Microorganisms Revenue Share by Company (2021-2026) Table 7. Global Antidiarrheal Microorganisms Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Antidiarrheal Microorganisms Sales Volume Share by Company (2021-2026) Table 9. Global Antidiarrheal Microorganisms Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Antidiarrheal Microorganisms Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antidiarrheal Microorganisms Key Company Manufacturing Base & Headquarters Table 12. Global Antidiarrheal Microorganisms Company, Product Type & Application Table 13. Global Antidiarrheal Microorganisms Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antidiarrheal Microorganisms by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Bifidobacterium Live Bacteria Table 18. Significant Companies of Bacillus Subtilis Live Bacteria Table 19. Significant Companies of Bacillus Licheniformis Live Bacteria Table 20. Significant Companies of Other Table 21. Global Antidiarrheal Microorganisms Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Antidiarrheal Microorganisms Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Antidiarrheal Microorganisms Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Antidiarrheal Microorganisms Sales Volume Share by Type (2021-2026) Table 25. Global Antidiarrheal Microorganisms Sales Volume Share by Type (2027-2032) Table 26. Global Antidiarrheal Microorganisms Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Antidiarrheal Microorganisms Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Antidiarrheal Microorganisms Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Antidiarrheal Microorganisms Sales Value Share by Type (2021-2026) Table 30. Global Antidiarrheal Microorganisms Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pharmacy Table 32. Significant Companies of Hospital Table 33. Significant Companies of Clinic Table 34. Significant Companies of Other Table 35. Global Antidiarrheal Microorganisms Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Antidiarrheal Microorganisms Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Antidiarrheal Microorganisms Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Antidiarrheal Microorganisms Sales Volume Share by Application (2021-2026) Table 39. Global Antidiarrheal Microorganisms Sales Volume Share by Application (2027-2032) Table 40. Global Antidiarrheal Microorganisms Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Antidiarrheal Microorganisms Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Antidiarrheal Microorganisms Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Antidiarrheal Microorganisms Sales Value Share by Application (2021-2026) Table 44. Global Antidiarrheal Microorganisms Sales Value Share by Application (2027-2032) Table 45. Global Antidiarrheal Microorganisms Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Antidiarrheal Microorganisms Sales by Region (2021-2026) & (K Units) Table 47. Global Antidiarrheal Microorganisms Sales Market Share by Region (2021-2026) Table 48. Global Antidiarrheal Microorganisms Sales by Region (2027-2032) & (K Units) Table 49. Global Antidiarrheal Microorganisms Sales Market Share by Region (2027-2032) Table 50. Global Antidiarrheal Microorganisms Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Antidiarrheal Microorganisms Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Antidiarrheal Microorganisms Sales Value Share by Region (2021-2026) Table 53. Global Antidiarrheal Microorganisms Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Antidiarrheal Microorganisms Sales Value Share by Region (2027-2032) Table 55. Global Antidiarrheal Microorganisms Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Antidiarrheal Microorganisms Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Antidiarrheal Microorganisms Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Antidiarrheal Microorganisms Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Antidiarrheal Microorganisms Sales by Country (2021-2026) & (K Units) Table 60. Global Antidiarrheal Microorganisms Sales Market Share by Country (2021-2026) Table 61. Global Antidiarrheal Microorganisms Sales by Country (2027-2032) & (K Units) Table 62. Global Antidiarrheal Microorganisms Sales Market Share by Country (2027-2032) Table 63. Global Antidiarrheal Microorganisms Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Antidiarrheal Microorganisms Sales Value Market Share by Country (2021-2026) Table 65. Global Antidiarrheal Microorganisms Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Antidiarrheal Microorganisms Sales Value Market Share by Country (2027-2032) Table 67. Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information Table 68. Zhejiang Jingxin Pharmaceutical Co., Ltd. Business Overview Table 69. Zhejiang Jingxin Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Zhejiang Jingxin Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 71. Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Development Table 72. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information Table 73. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview Table 74. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 76. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Development Table 77. Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Company Information Table 78. Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Business Overview Table 79. Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 81. Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Recent Development Table 82. Livzon Pharmaceutical Factory of Livzon Group Company Information Table 83. Livzon Pharmaceutical Factory of Livzon Group Business Overview Table 84. Livzon Pharmaceutical Factory of Livzon Group Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Livzon Pharmaceutical Factory of Livzon Group Antidiarrheal Microorganisms Product Portfolio Table 86. Livzon Pharmaceutical Factory of Livzon Group Recent Development Table 87. Sinovac Biotech Co., Ltd. Company Information Table 88. Sinovac Biotech Co., Ltd. Business Overview Table 89. Sinovac Biotech Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sinovac Biotech Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 91. Sinovac Biotech Co., Ltd. Recent Development Table 92. Jincheng Haisi Pharmaceutical Co., Ltd. Company Information Table 93. Jincheng Haisi Pharmaceutical Co., Ltd. Business Overview Table 94. Jincheng Haisi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Jincheng Haisi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 96. Jincheng Haisi Pharmaceutical Co., Ltd. Recent Development Table 97. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Company Information Table 98. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Business Overview Table 99. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 101. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Recent Development Table 102. Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Company Information Table 103. Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Business Overview Table 104. Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 106. Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Recent Development Table 107. Beijing Hanmei Pharmaceutical Co., Ltd. Company Information Table 108. Beijing Hanmei Pharmaceutical Co., Ltd. Business Overview Table 109. Beijing Hanmei Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Beijing Hanmei Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 111. Beijing Hanmei Pharmaceutical Co., Ltd. Recent Development Table 112. VWR Company Information Table 113. VWR Business Overview Table 114. VWR Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. VWR Antidiarrheal Microorganisms Product Portfolio Table 116. VWR Recent Development Table 117. Vermicon AG Company Information Table 118. Vermicon AG Business Overview Table 119. Vermicon AG Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Vermicon AG Antidiarrheal Microorganisms Product Portfolio Table 121. Vermicon AG Recent Development Table 122. Tangsonsbio Company Information Table 123. Tangsonsbio Business Overview Table 124. Tangsonsbio Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Tangsonsbio Antidiarrheal Microorganisms Product Portfolio Table 126. Tangsonsbio Recent Development Table 127. Pepto Bismol Company Information Table 128. Pepto Bismol Business Overview Table 129. Pepto Bismol Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Pepto Bismol Antidiarrheal Microorganisms Product Portfolio Table 131. Pepto Bismol Recent Development Table 132. Goerlich Pharma Company Information Table 133. Goerlich Pharma Business Overview Table 134. Goerlich Pharma Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Goerlich Pharma Antidiarrheal Microorganisms Product Portfolio Table 136. Goerlich Pharma Recent Development Table 137. Chr. Hansen Company Information Table 138. Chr. Hansen Business Overview Table 139. Chr. Hansen Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Chr. Hansen Antidiarrheal Microorganisms Product Portfolio Table 141. Chr. Hansen Recent Development Table 142. Biofermin Company Information Table 143. Biofermin Business Overview Table 144. Biofermin Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Biofermin Antidiarrheal Microorganisms Product Portfolio Table 146. Biofermin Recent Development Table 147. Aptalis Pharma SAS Company Information Table 148. Aptalis Pharma SAS Business Overview Table 149. Aptalis Pharma SAS Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Aptalis Pharma SAS Antidiarrheal Microorganisms Product Portfolio Table 151. Aptalis Pharma SAS Recent Development Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Antidiarrheal Microorganisms Distributors List Table 155. Antidiarrheal Microorganisms Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Antidiarrheal Microorganisms Product Image Figure 2. Global Antidiarrheal Microorganisms Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidiarrheal Microorganisms Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antidiarrheal Microorganisms Sales (2021-2032) & (K Units) Figure 5. Global Antidiarrheal Microorganisms Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Antidiarrheal Microorganisms Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Bifidobacterium Live Bacteria Image Figure 10. Bacillus Subtilis Live Bacteria Image Figure 11. Bacillus Licheniformis Live Bacteria Image Figure 12. Other Image Figure 13. Global Antidiarrheal Microorganisms Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Antidiarrheal Microorganisms Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Antidiarrheal Microorganisms Sales Volume Share by Type (2021-2032) Figure 16. Global Antidiarrheal Microorganisms Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Antidiarrheal Microorganisms Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Antidiarrheal Microorganisms Sales Value Share by Type (2021-2032) Figure 19. Pharmacy Image Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Other Image Figure 23. Global Antidiarrheal Microorganisms Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Antidiarrheal Microorganisms Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Antidiarrheal Microorganisms Sales Volume Share by Application (2021-2032) Figure 26. Global Antidiarrheal Microorganisms Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Antidiarrheal Microorganisms Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Antidiarrheal Microorganisms Sales Value Share by Application (2021-2032) Figure 29. Global Antidiarrheal Microorganisms Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Antidiarrheal Microorganisms Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Antidiarrheal Microorganisms Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Antidiarrheal Microorganisms Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Antidiarrheal Microorganisms Sales Value (2021-2032) & (US$ Million) Figure 34. North America Antidiarrheal Microorganisms Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Antidiarrheal Microorganisms Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Antidiarrheal Microorganisms Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Antidiarrheal Microorganisms Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Antidiarrheal Microorganisms Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Antidiarrheal Microorganisms Sales Value (2021-2032) & (US$ Million) Figure 40. South America Antidiarrheal Microorganisms Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Antidiarrheal Microorganisms Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Antidiarrheal Microorganisms Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Antidiarrheal Microorganisms Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Antidiarrheal Microorganisms Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Bifidobacterium Live Bacteria
  • Bacillus Subtilis Live Bacteria
  • Bacillus Licheniformis Live Bacteria
  • Other
Applications
  • Pharmacy
  • Hospital
  • Clinic
  • Other
Companies covered
  • Zhejiang Jingxin Pharmaceutical Co., Ltd.
  • Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  • Inner Mongolia Shuangqi Pharmaceutical Co., Ltd.
  • Livzon Pharmaceutical Factory of Livzon Group
  • Sinovac Biotech Co., Ltd.
  • Jincheng Haisi Pharmaceutical Co., Ltd.
  • Hangzhou Yuanda Biopharmaceutical Co., Ltd.
  • Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd.
  • Beijing Hanmei Pharmaceutical Co., Ltd.
  • VWR
  • Vermicon AG
  • Tangsonsbio
  • Pepto Bismol
  • Goerlich Pharma
  • Chr. Hansen
  • Biofermin
  • Aptalis Pharma SAS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antidiarrheal Microorganisms Sales Value (2021-2032)
  4. 1.2.2 Global Antidiarrheal Microorganisms Sales Volume (2021-2032)
  5. 1.2.3 Global Antidiarrheal Microorganisms Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antidiarrheal Microorganisms Market Dynamics
  1. 2.1 Antidiarrheal Microorganisms Industry Trends
  2. 2.2 Antidiarrheal Microorganisms Industry Drivers
  3. 2.3 Antidiarrheal Microorganisms Industry Opportunities and Challenges
  4. 2.4 Antidiarrheal Microorganisms Industry Restraints
3 Antidiarrheal Microorganisms Market by Company
  1. 3.1 Global Antidiarrheal Microorganisms Company Revenue Ranking in 2025
  2. 3.2 Global Antidiarrheal Microorganisms Revenue by Company (2021-2026)
  3. 3.3 Global Antidiarrheal Microorganisms Sales Volume by Company (2021-2026)
  4. 3.4 Global Antidiarrheal Microorganisms Average Price by Company (2021-2026)
  5. 3.5 Global Antidiarrheal Microorganisms Company Ranking (2024-2026)
  6. 3.6 Global Antidiarrheal Microorganisms Company Manufacturing Base and Headquarters
  7. 3.7 Global Antidiarrheal Microorganisms Company Product Type and Application
  8. 3.8 Global Antidiarrheal Microorganisms Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antidiarrheal Microorganisms Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antidiarrheal Microorganisms Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antidiarrheal Microorganisms Market by Type
  1. 4.1 Antidiarrheal Microorganisms Type Introduction
  2. 4.1.1 Bifidobacterium Live Bacteria
  3. 4.1.2 Bacillus Subtilis Live Bacteria
  4. 4.1.3 Bacillus Licheniformis Live Bacteria
  5. 4.1.4 Other
  6. 4.2 Global Antidiarrheal Microorganisms Sales Volume by Type
  7. 4.2.1 Global Antidiarrheal Microorganisms Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Antidiarrheal Microorganisms Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Antidiarrheal Microorganisms Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Antidiarrheal Microorganisms Sales Value by Type
  11. 4.3.1 Global Antidiarrheal Microorganisms Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Antidiarrheal Microorganisms Sales Value by Type (2021-2032)
  13. 4.3.3 Global Antidiarrheal Microorganisms Sales Value Share by Type (2021-2032)
5 Antidiarrheal Microorganisms Market by Application
  1. 5.1 Antidiarrheal Microorganisms Application Introduction
  2. 5.1.1 Pharmacy
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.1.4 Other
  6. 5.2 Global Antidiarrheal Microorganisms Sales Volume by Application
  7. 5.2.1 Global Antidiarrheal Microorganisms Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antidiarrheal Microorganisms Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Antidiarrheal Microorganisms Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Antidiarrheal Microorganisms Sales Value by Application
  11. 5.3.1 Global Antidiarrheal Microorganisms Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Antidiarrheal Microorganisms Sales Value by Application (2021-2032)
  13. 5.3.3 Global Antidiarrheal Microorganisms Sales Value Share by Application (2021-2032)
6 Antidiarrheal Microorganisms Regional Sales and Value Analysis
  1. 6.1 Global Antidiarrheal Microorganisms Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antidiarrheal Microorganisms Sales by Region (2021-2032)
  3. 6.2.1 Global Antidiarrheal Microorganisms Sales by Region: 2021-2026
  4. 6.2.2 Global Antidiarrheal Microorganisms Sales by Region (2027-2032)
  5. 6.3 Global Antidiarrheal Microorganisms Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antidiarrheal Microorganisms Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antidiarrheal Microorganisms Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antidiarrheal Microorganisms Sales Value by Region (2027-2032)
  9. 6.5 Global Antidiarrheal Microorganisms Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antidiarrheal Microorganisms Sales Value (2021-2032)
  12. 6.6.2 North America Antidiarrheal Microorganisms Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antidiarrheal Microorganisms Sales Value (2021-2032)
  15. 6.7.2 Europe Antidiarrheal Microorganisms Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antidiarrheal Microorganisms Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antidiarrheal Microorganisms Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antidiarrheal Microorganisms Sales Value (2021-2032)
  21. 6.9.2 South America Antidiarrheal Microorganisms Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antidiarrheal Microorganisms Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antidiarrheal Microorganisms Sales Value Share by Country, 2025 VS 2032
7 Antidiarrheal Microorganisms Country-level Sales and Value Analysis
  1. 7.1 Global Antidiarrheal Microorganisms Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antidiarrheal Microorganisms Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antidiarrheal Microorganisms Sales by Country (2021-2032)
  4. 7.3.1 Global Antidiarrheal Microorganisms Sales by Country (2021-2026)
  5. 7.3.2 Global Antidiarrheal Microorganisms Sales by Country (2027-2032)
  6. 7.4 Global Antidiarrheal Microorganisms Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antidiarrheal Microorganisms Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antidiarrheal Microorganisms Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antidiarrheal Microorganisms Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antidiarrheal Microorganisms Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antidiarrheal Microorganisms Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Jingxin Pharmaceutical Co., Ltd.
  2. 8.1.1 Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Zhejiang Jingxin Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Jingxin Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  6. 8.1.5 Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  8. 8.2.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  12. 8.2.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd.
  14. 8.3.1 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  18. 8.3.5 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Livzon Pharmaceutical Factory of Livzon Group
  20. 8.4.1 Livzon Pharmaceutical Factory of Livzon Group Company Information
  21. 8.4.2 Livzon Pharmaceutical Factory of Livzon Group Business Overview
  22. 8.4.3 Livzon Pharmaceutical Factory of Livzon Group Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Livzon Pharmaceutical Factory of Livzon Group Antidiarrheal Microorganisms Product Portfolio
  24. 8.4.5 Livzon Pharmaceutical Factory of Livzon Group Recent Developments
  25. 8.5 Sinovac Biotech Co., Ltd.
  26. 8.5.1 Sinovac Biotech Co., Ltd. Company Information
  27. 8.5.2 Sinovac Biotech Co., Ltd. Business Overview
  28. 8.5.3 Sinovac Biotech Co., Ltd. Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sinovac Biotech Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  30. 8.5.5 Sinovac Biotech Co., Ltd. Recent Developments
  31. 8.6 Jincheng Haisi Pharmaceutical Co., Ltd.
  32. 8.6.1 Jincheng Haisi Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Jincheng Haisi Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Jincheng Haisi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jincheng Haisi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  36. 8.6.5 Jincheng Haisi Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Hangzhou Yuanda Biopharmaceutical Co., Ltd.
  38. 8.7.1 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  42. 8.7.5 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd.
  44. 8.8.1 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  48. 8.8.5 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Beijing Hanmei Pharmaceutical Co., Ltd.
  50. 8.9.1 Beijing Hanmei Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Beijing Hanmei Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Beijing Hanmei Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Beijing Hanmei Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  54. 8.9.5 Beijing Hanmei Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 VWR
  56. 8.10.1 VWR Company Information
  57. 8.10.2 VWR Business Overview
  58. 8.10.3 VWR Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 VWR Antidiarrheal Microorganisms Product Portfolio
  60. 8.10.5 VWR Recent Developments
  61. 8.11 Vermicon AG
  62. 8.11.1 Vermicon AG Company Information
  63. 8.11.2 Vermicon AG Business Overview
  64. 8.11.3 Vermicon AG Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Vermicon AG Antidiarrheal Microorganisms Product Portfolio
  66. 8.11.5 Vermicon AG Recent Developments
  67. 8.12 Tangsonsbio
  68. 8.12.1 Tangsonsbio Company Information
  69. 8.12.2 Tangsonsbio Business Overview
  70. 8.12.3 Tangsonsbio Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Tangsonsbio Antidiarrheal Microorganisms Product Portfolio
  72. 8.12.5 Tangsonsbio Recent Developments
  73. 8.13 Pepto Bismol
  74. 8.13.1 Pepto Bismol Company Information
  75. 8.13.2 Pepto Bismol Business Overview
  76. 8.13.3 Pepto Bismol Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Pepto Bismol Antidiarrheal Microorganisms Product Portfolio
  78. 8.13.5 Pepto Bismol Recent Developments
  79. 8.14 Goerlich Pharma
  80. 8.14.1 Goerlich Pharma Company Information
  81. 8.14.2 Goerlich Pharma Business Overview
  82. 8.14.3 Goerlich Pharma Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Goerlich Pharma Antidiarrheal Microorganisms Product Portfolio
  84. 8.14.5 Goerlich Pharma Recent Developments
  85. 8.15 Chr. Hansen
  86. 8.15.1 Chr. Hansen Company Information
  87. 8.15.2 Chr. Hansen Business Overview
  88. 8.15.3 Chr. Hansen Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Chr. Hansen Antidiarrheal Microorganisms Product Portfolio
  90. 8.15.5 Chr. Hansen Recent Developments
  91. 8.16 Biofermin
  92. 8.16.1 Biofermin Company Information
  93. 8.16.2 Biofermin Business Overview
  94. 8.16.3 Biofermin Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Biofermin Antidiarrheal Microorganisms Product Portfolio
  96. 8.16.5 Biofermin Recent Developments
  97. 8.17 Aptalis Pharma SAS
  98. 8.17.1 Aptalis Pharma SAS Company Information
  99. 8.17.2 Aptalis Pharma SAS Business Overview
  100. 8.17.3 Aptalis Pharma SAS Antidiarrheal Microorganisms Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Aptalis Pharma SAS Antidiarrheal Microorganisms Product Portfolio
  102. 8.17.5 Aptalis Pharma SAS Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antidiarrheal Microorganisms Value Chain Analysis
  2. 9.1.1 Antidiarrheal Microorganisms Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antidiarrheal Microorganisms Sales Mode & Process
  6. 9.2 Antidiarrheal Microorganisms Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antidiarrheal Microorganisms Distributors
  9. 9.2.3 Antidiarrheal Microorganisms Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst